• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柚皮苷,一种具有抗病毒和抗炎作用的类黄酮:一种有前途的对抗 COVID-19 的治疗策略。

Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19.

机构信息

Student Research Committee, Nutrition Research Center, School of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Phytother Res. 2020 Dec;34(12):3137-3147. doi: 10.1002/ptr.6781. Epub 2020 Jul 2.

DOI:10.1002/ptr.6781
PMID:32613637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361426/
Abstract

At the end of 2019, a novel flu-like coronavirus named COVID-19 (coronavirus disease 2019) was recognized by World Health Organization. No specific treatments exist for COVID-19 at this time. New evidence suggests that therapeutic options focusing on antiviral agents may alleviate COVID-19 symptoms as well as those that lead to the decrease in the inflammatory responses. Flavonoids, as phenolic compounds, have attracted considerable attention due to their various biological properties. In this review, the promising effects and possible mechanisms of action of naringenin, a citrus-derived flavonoid, against COVID-19 were discussed. We searched PubMed/Medline, Science direct, Scopus, and Google Scholar databases up to March 2020 using the definitive keywords. The evidence reviewed here indicates that naringenin might exert therapeutic effects against COVID-19 through the inhibition of COVID-19 main protease, 3-chymotrypsin-like protease (3CLpro), and reduction of angiotensin converting enzyme receptors activity. One of the other mechanisms by which naringenin might exert therapeutic effects against COVID-19 is, at least partly, by attenuating inflammatory responses. The antiviral activity of the flavanone naringenin against some viruses has also been reported. On the whole, the favorable effects of naringenin lead to a conclusion that naringenin may be a promising treatment strategy against COVID-19.

摘要

2019 年末,世界卫生组织(WHO)确认了一种新型的流感样冠状病毒,名为 COVID-19(2019 年冠状病毒病)。目前,尚无针对 COVID-19 的特定治疗方法。新的证据表明,专注于抗病毒药物的治疗选择可能会缓解 COVID-19 症状以及导致炎症反应下降的症状。类黄酮作为酚类化合物,由于其多种生物学特性而受到广泛关注。在这篇综述中,讨论了源自柑橘的类黄酮柚皮素针对 COVID-19 的有希望的作用和可能的作用机制。我们使用明确的关键词,在 2020 年 3 月之前,在 PubMed/Medline、Science direct、Scopus 和 Google Scholar 数据库中进行了搜索。这里综述的证据表明,柚皮素可能通过抑制 COVID-19 主要蛋白酶(3CLpro)和降低血管紧张素转换酶受体活性,对 COVID-19 发挥治疗作用。柚皮素对 COVID-19 发挥治疗作用的另一种机制是,至少部分通过减轻炎症反应。也有报道称,该黄酮类化合物柚皮素对某些病毒具有抗病毒活性。总的来说,柚皮素的有利影响得出的结论是,柚皮素可能是针对 COVID-19 的一种有前途的治疗策略。

相似文献

1
Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19.柚皮苷,一种具有抗病毒和抗炎作用的类黄酮:一种有前途的对抗 COVID-19 的治疗策略。
Phytother Res. 2020 Dec;34(12):3137-3147. doi: 10.1002/ptr.6781. Epub 2020 Jul 2.
2
Perspective: The Potential Effects of Naringenin in COVID-19.观点:柚皮素在 COVID-19 中的潜在作用。
Front Immunol. 2020 Sep 25;11:570919. doi: 10.3389/fimmu.2020.570919. eCollection 2020.
3
Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data.用于 COVID-19 的抗病毒药物:作用机制和药理学数据。
Eur Rev Med Pharmacol Sci. 2021 Jun;25(11):4163-4173. doi: 10.26355/eurrev_202106_26060.
4
A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.柚皮苷,一种源自柑橘的类黄酮,对非酒精性脂肪性肝病风险因素影响的全面系统评价。
Adv Nutr. 2021 Mar 31;12(2):413-428. doi: 10.1093/advances/nmaa106.
5
The Discovery of Naringenin as Endolysosomal Two-Pore Channel Inhibitor and Its Emerging Role in SARS-CoV-2 Infection.柚皮素作为内溶酶体双孔通道抑制剂的发现及其在 SARS-CoV-2 感染中的新作用。
Cells. 2021 May 7;10(5):1130. doi: 10.3390/cells10051130.
6
Niclosamide for Covid-19: bridging the gap.尼氯硝唑治疗 COVID-19:弥合差距。
Mol Biol Rep. 2021 Dec;48(12):8195-8202. doi: 10.1007/s11033-021-06770-7. Epub 2021 Oct 18.
7
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).药用植物和次生代谢物抗严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的作用机制。
Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130.
8
The anti-Zika virus and anti-tumoral activity of the citrus flavanone lipophilic naringenin-based compounds.基于柑橘类黄酮亲脂柚皮素的化合物的抗寨卡病毒和抗肿瘤活性。
Chem Biol Interact. 2020 Nov 1;331:109218. doi: 10.1016/j.cbi.2020.109218. Epub 2020 Sep 8.
9
Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.针对 SARS-CoV-2 细胞进入机制的靶向治疗策略:体外和体内研究的系统评价。
J Cell Physiol. 2021 Apr;236(4):2364-2392. doi: 10.1002/jcp.30032. Epub 2020 Sep 9.
10
Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review.类黄酮作为有前途的抗 SARS-CoV-2 感染的抗病毒药物:一种机制综述。
Molecules. 2021 Jun 25;26(13):3900. doi: 10.3390/molecules26133900.

引用本文的文献

1
Network Pharmacology and Experiment Verification-Based Strategy for Exploring the Mechanisms of Shuqing Granule in the Treatment of COVID-19.基于网络药理学和实验验证的疏清颗粒治疗新型冠状病毒肺炎作用机制探究策略
Pharmaceuticals (Basel). 2025 Aug 18;18(8):1216. doi: 10.3390/ph18081216.
2
Antiviral Activity of Brazilian Propolis from Stingless Bees Against Rotavirus.无刺蜂产巴西蜂胶对轮状病毒的抗病毒活性
Microorganisms. 2025 Jun 19;13(6):1424. doi: 10.3390/microorganisms13061424.
3
Identification and Characterization of Antiviral Activity of Synthetic Compounds Against Mayaro Virus.合成化合物对马亚罗病毒抗病毒活性的鉴定与表征
Pharmaceuticals (Basel). 2025 May 13;18(5):717. doi: 10.3390/ph18050717.
4
The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer's Disease: Mechanisms and Therapeutic Potential.特定类黄酮在调节阿尔茨海默病神经炎症中的作用:机制与治疗潜力
Brain Sci. 2025 May 5;15(5):485. doi: 10.3390/brainsci15050485.
5
Bioactive Molecules from Tropical American Plants: Potential Anti-Inflammatory Agents for Cytokine Storm Management.来自热带美洲植物的生物活性分子:用于细胞因子风暴管理的潜在抗炎剂。
Molecules. 2025 Mar 27;30(7):1486. doi: 10.3390/molecules30071486.
6
Exploration of Conventional and FDM-Mediated 3D Printed Tablets Fabricated Using HME-Based Filaments for pH-Dependent Drug Delivery.探索使用基于热熔挤出的长丝制造的传统和熔融沉积建模介导的3D打印片剂用于pH依赖性药物递送。
AAPS PharmSciTech. 2025 Mar 27;26(4):96. doi: 10.1208/s12249-025-03088-6.
7
Remedying SARS-CoV-2 through nature: a review highlighting the potentiality of herbs, trees, mushrooms, and endophytic microorganisms in controlling Coronavirus.利用自然疗法对抗新冠病毒:一篇综述,强调草药、树木、蘑菇和内生微生物在控制冠状病毒方面的潜力。
Planta. 2025 Mar 16;261(4):89. doi: 10.1007/s00425-025-04647-8.
8
Botanical Flavonoids: Efficacy, Absorption, Metabolism and Advanced Pharmaceutical Technology for Improving Bioavailability.植物类黄酮:功效、吸收、代谢及提高生物利用度的先进制药技术
Molecules. 2025 Mar 6;30(5):1184. doi: 10.3390/molecules30051184.
9
Substrate Selectivities of GH78 α-L-Rhamnosidases from Human Gut Bacteria on Dietary Flavonoid Glycosides.人体肠道细菌中GH78 α-L-鼠李糖苷酶对膳食类黄酮糖苷的底物选择性
Molecules. 2025 Feb 20;30(5):980. doi: 10.3390/molecules30050980.
10
Network Pharmacology and Molecular Docking: Exploring the Mechanism of Peppermint in Mastitis Prevention and Treatment in Dairy Cows.网络药理学与分子对接:探究薄荷预防和治疗奶牛乳腺炎的机制
Vet Sci. 2025 Feb 5;12(2):129. doi: 10.3390/vetsci12020129.

本文引用的文献

1
Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2.柑橘类水果富含用于免疫调节和潜在靶向血管紧张素转换酶2(ACE2)的类黄酮。
Nat Prod Bioprospect. 2022 Feb 14;12(1):4. doi: 10.1007/s13659-022-00325-4.
2
Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19.油酰乙醇酰胺,一种生物活性脂质酰胺,作为一种有前途的冠状病毒/COVID-19 治疗策略。
Arch Med Res. 2020 Jul;51(5):464-467. doi: 10.1016/j.arcmed.2020.04.006. Epub 2020 Apr 15.
3
Structural basis of SARS-CoV-2 3CL and anti-COVID-19 drug discovery from medicinal plants.严重急性呼吸综合征冠状病毒2 3CL的结构基础与药用植物抗新型冠状病毒药物发现
J Pharm Anal. 2020 Aug;10(4):313-319. doi: 10.1016/j.jpha.2020.03.009. Epub 2020 Mar 26.
4
Balancing risk and benefit during coronavirus.在新冠疫情期间权衡风险与收益。
Blood. 2020 May 21;135(21):1817. doi: 10.1182/blood.2020006279.
5
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.新型冠状病毒肺炎感染:人类冠状病毒的起源、传播及特征
J Adv Res. 2020 Mar 16;24:91-98. doi: 10.1016/j.jare.2020.03.005. eCollection 2020 Jul.
6
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?新型冠状病毒肺炎与非甾体抗炎药和皮质类固醇治疗:我们是否应在临床环境中限制其使用?
Ecancermedicalscience. 2020 Mar 30;14:1023. doi: 10.3332/ecancer.2020.1023. eCollection 2020.
7
Redefining vulnerability in the era of COVID-19.重新定义新冠疫情时代的脆弱性。
Lancet. 2020 Apr 4;395(10230):1089. doi: 10.1016/S0140-6736(20)30757-1.
8
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.从基因组角度看 SARS-CoV-2 的起源与出现。
Cell. 2020 Apr 16;181(2):223-227. doi: 10.1016/j.cell.2020.03.035. Epub 2020 Mar 26.
9
Potential Effects of Coronaviruses on the Cardiovascular System: A Review.冠状病毒对心血管系统的潜在影响:综述。
JAMA Cardiol. 2020 Jul 1;5(7):831-840. doi: 10.1001/jamacardio.2020.1286.
10
Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?炎症性肠病患者感染 COVID-19 的风险是否增加?
J Crohns Colitis. 2020 Sep 16;14(9):1334-1336. doi: 10.1093/ecco-jcc/jjaa061.